Derma Beauty Group Ltd 14226520 false 2024-02-28 2025-02-27 2025-02-27 The principal activity of the company is holding company Digita Accounts Production Advanced 6.30.9574.0 true false 14226520 2024-02-28 2025-02-27 14226520 2025-02-27 14226520 bus:OrdinaryShareClass1 2025-02-27 14226520 bus:SmallEntities 2024-02-28 2025-02-27 14226520 bus:AuditExemptWithAccountantsReport 2024-02-28 2025-02-27 14226520 bus:FilletedAccounts 2024-02-28 2025-02-27 14226520 bus:SmallCompaniesRegimeForAccounts 2024-02-28 2025-02-27 14226520 bus:RegisteredOffice 2024-02-28 2025-02-27 14226520 bus:Director1 2024-02-28 2025-02-27 14226520 bus:OrdinaryShareClass1 2024-02-28 2025-02-27 14226520 bus:PrivateLimitedCompanyLtd 2024-02-28 2025-02-27 14226520 countries:AllCountries 2024-02-28 2025-02-27 14226520 core:CostValuation 2024-02-27 14226520 2023-03-01 2024-02-27 14226520 2024-02-27 14226520 bus:OrdinaryShareClass1 2024-02-27 iso4217:GBP xbrli:pure xbrli:shares

Derma Beauty Group Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 27 February 2025

Registration number: 14226520

 

Derma Beauty Group Ltd

Contents

Statement of financial position

1

Notes to the Unaudited Financial Statements

2 to 3

 

Derma Beauty Group Ltd

(Registration number: 14226520)
Statement of financial position as at 27 February 2025

Note

2025
£

2024
£

Fixed assets

 

Investments

4

100

100

Current assets

 

Cash at bank and in hand

 

100

100

Net assets

 

200

200

Capital and reserves

 

Called up share capital

5

200

200

Shareholders' funds

 

200

200

For the financial year ending 27 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the director on 26 November 2025
 

.........................................
Miss R Londors
Director

 

Derma Beauty Group Ltd

Notes to the Unaudited Financial Statements for the Year Ended 27 February 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Solo House
The Courtyard
London Road
Horsham
West Sussex
RH12 1AT

These financial statements were authorised for issue by the director on 26 November 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Derma Beauty Group Ltd

Notes to the Unaudited Financial Statements for the Year Ended 27 February 2025

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

4

Investments

2025
£

2024
£

Investments in subsidiaries

100

100

Subsidiaries

£

Cost or valuation

At 28 February 2024

100

Provision

Carrying amount

At 27 February 2025

100

At 27 February 2024

100

5

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary of £1 each

200

200

200

200